MEDIVATION INC's ticker is MDVN and the CUSIP is 58501N101. A total of 9 filers reported holding MEDIVATION INC in Q4 2012. The put-call ratio across all filers is 1.79 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2016 | $380,000 | +31.0% | 6,300 | 0.0% | 0.01% | +30.0% |
| Q1 2016 | $290,000 | -8.8% | 6,300 | -4.2% | 0.01% | -9.1% |
| Q4 2015 | $318,000 | +15800.0% | 6,573 | +54675.0% | 0.01% | – |
| Q1 2015 | $2,000 | +100.0% | 12 | 0.0% | 0.00% | – |
| Q4 2014 | $1,000 | 0.0% | 12 | -25.0% | 0.00% | – |
| Q2 2014 | $1,000 | -50.0% | 16 | -56.8% | 0.00% | – |
| Q1 2014 | $2,000 | -97.3% | 37 | -97.5% | 0.00% | -100.0% |
| Q2 2013 | $74,000 | -27.5% | 1,500 | -25.0% | 0.00% | -50.0% |
| Q4 2012 | $102,000 | -9.7% | 2,000 | 0.0% | 0.00% | -33.3% |
| Q3 2012 | $113,000 | +175.6% | 2,000 | -16.7% | 0.00% | +200.0% |
| Q3 2011 | $41,000 | -19.6% | 2,400 | 0.0% | 0.00% | 0.0% |
| Q2 2011 | $51,000 | -80.6% | 2,400 | -83.0% | 0.00% | -85.7% |
| Q1 2011 | $263,000 | +22.9% | 14,100 | 0.0% | 0.01% | +16.7% |
| Q4 2010 | $214,000 | – | 14,100 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knoll Capital Management, LLC | 2,504,101 | $123,202,000 | 84.26% |
| BB BIOTECH AG | 1,449,706 | $71,326,000 | 5.14% |
| SECTORAL ASSET MANAGEMENT INC | 2,717,173 | $133,685,000 | 3.95% |
| PFM Health Sciences, LP | 2,417,306 | $118,931,000 | 2.47% |
| Bain Capital Public Equity Management, LLC | 2,127,075 | $104,652,000 | 2.45% |
| Partner Investment Management, L.P. | 205,257 | $10,099,000 | 2.28% |
| TRAXIS PARTNERS LP | 60,000 | $2,952,000 | 2.28% |
| HealthCor Management, L.P. | 650,000 | $31,980,000 | 1.93% |
| Loeb Offshore Management LP | 73,825 | $3,632,000 | 1.86% |
| QVT Financial LP | 547,628 | $26,943,000 | 1.81% |